Benzodiazepine use and multidimensional health burden in severe psychiatric disorders: Impaired quality of life, metabolic comorbidities, and adverse effects in a large cross-sectional study.
- DOI
- 10.1192/j.eurpsy.2025.10098
- Published
- 2025 Sep 3
- Container
- European psychiatry : the journal of the Association of European Psychiatrists
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1192/j.eurpsy.2025.10098,
title = {Benzodiazepine use and multidimensional health burden in severe psychiatric disorders: Impaired quality of life, metabolic comorbidities, and adverse effects in a large cross-sectional study.},
author = {Achour V and Faugere M and Maakaron E and Gavat J and Fond G and Lançon C and Korchia T},
year = {2025},
journal = {European psychiatry : the journal of the Association of European Psychiatrists},
doi = {10.1192/j.eurpsy.2025.10098},
url = {https://doi.org/10.1192/j.eurpsy.2025.10098}
}RIS
TY - JOUR TI - Benzodiazepine use and multidimensional health burden in severe psychiatric disorders: Impaired quality of life, metabolic comorbidities, and adverse effects in a large cross-sectional study. AU - Achour V AU - Faugere M AU - Maakaron E AU - Gavat J AU - Fond G AU - Lançon C AU - Korchia T PY - 2025 JO - European psychiatry : the journal of the Association of European Psychiatrists DO - 10.1192/j.eurpsy.2025.10098 UR - https://doi.org/10.1192/j.eurpsy.2025.10098 ER -
APA
V, A., M, F., E, M., J, G., G, F., C, L., & T, K. (2025). Benzodiazepine use and multidimensional health burden in severe psychiatric disorders: Impaired quality of life, metabolic comorbidities, and adverse effects in a large cross-sectional study.. European psychiatry : the journal of the Association of European Psychiatrists. https://doi.org/10.1192/j.eurpsy.2025.10098
Source records
- pubmed · retrieved 2026-09-27T12:02:16.438Z